VRNA Stock Analysis Overview
What this means: InvestorsObserver gives Verona Pharma Plc ADR (VRNA) an overall rank of 45, which is below average. Verona Pharma Plc ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 45 means that 55% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
VRNA Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
VRNA Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
VRNA Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
VRNA Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
VRNA Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
VRNA Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
VRNA Stock Analysis Overview
What this means: InvestorsObserver gives Verona Pharma Plc ADR (VRNA) an overall rank of 45, which is below average. Verona Pharma Plc ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 45 means that 55% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.